Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Cheryl Louw"'
Autor:
Irina Yacobson, Valentine Wanga, Khatija Ahmed, Tsungai Chipato, Peter Gichangi, James Kiarie, Cheryl Louw, Susan Morrison, Margaret Moss, Nelly R. Mugo, Thesla Palanee-Phillips, Melanie Pleaner, Caitlin W. Scoville, Katherine K. Thomas, Kavita Nanda
Publikováno v:
Contraception: X, Vol 5, Iss , Pp 100092- (2023)
Objectives: To assess the rates of failed insertion, expulsion, and perforation when intrauterine device (IUD) insertions were done by newly trained clinicians, and to examine factors that may affect these outcomes. Study design: We evaluated skill-b
Externí odkaz:
https://doaj.org/article/72d8cff997b846b585ae4cb89e10fc59
Autor:
Annalene Nel, Linda-Gail Bekker, Elizabeth Bukusi, Elizabeth Hellstrӧm, Philip Kotze, Cheryl Louw, Francis Martinson, Gileard Masenga, Elizabeth Montgomery, Nelisiwe Ndaba, Ariane van der Straten, Neliëtte van Niekerk, Cynthia Woodsong
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0147743 (2016)
BACKGROUND:This was the first microbicide trial conducted in Africa to evaluate an antiretroviral-containing vaginal ring as an HIV prevention technology for women. OBJECTIVES:The trial assessed and compared the safety, acceptability and adherence to
Externí odkaz:
https://doaj.org/article/f6cd4b59c1bf40db814c7587b1ad1bc7
Autor:
Annaléne Nel, Cheryl Louw, Elizabeth Hellstrom, Sarah L Braunstein, Ina Treadwell, Melanie Marais, Martie de Villiers, Jannie Hugo, Inge Paschke, Chrisna Andersen, Janneke van de Wijgert
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e21528 (2011)
BACKGROUND: The suitability of populations of sexually active women in Madibeng (North-West Province) and Mbekweni (Western Cape), South Africa, for a Phase III vaginal microbicide trial was evaluated. METHODS: Sexually active women 18-35 years not k
Externí odkaz:
https://doaj.org/article/f88bcc80288e4164ada079532c747b1b
Autor:
Ivana, Beesham, Urvi M, Parikh, John W, Mellors, Dvora L, Joseph Davey, Renee, Heffron, Thesla, Palanee-Phillips, Shannon L, Bosman, Mags, Beksinska, Jennifer, Smit, Khatija, Ahmed, Heeran, Makkan, Pearl, Selepe, Cheryl, Louw, Philip, Kotze, G Justus, Hofmeyr, Mandisa, Singata-Madliki, Helen, Rees, Jared M, Baeten, Carole, Wallis
Publikováno v:
Journal of acquired immune deficiency syndromes (1999), vol 91, iss 2
BackgroundPretreatment HIV drug resistance (PDR) undermines individual treatment success and threatens the achievement of UNAIDS 95-95-95 targets. In many African countries, limited data are available on PDR as detection of recent HIV infection is un
Autor:
Shabir A Madhi, Dhayendre Moodley, Sherika Hanley, Moherndran Archary, Zaheer Hoosain, Umesh Lalloo, Cheryl Louw, Lee Fairlie, Leon Frederik Fouche, Mduduzi S L Masilela, Nishanta Singh, Coert Grobbelaar, Khatija Ahmed, Gabriella Benadé, Sutika Bhikha, As'ad Ebrahim Bhorat, Qasim Bhorat, Natasha Joseph, Keertan Dheda, Aliasgar Esmail, Sharne Foulkes, Ameena Goga, Aylin Oommen Jose, Gertruida Kruger, Dishiki J Kalonji, Natasha Lalloo, Johan J Lombaard, Anthonet Lombard Koen, Angelique Kany Luabeya, Rosie Mngqibisa, Friedrich G Petrick, Annah Pitsi, Michele Tameris, Asha Thombrayil, Pieter-Louis Vollgraaff, Shane Cloney-Clark, Mingzhu Zhu, Chijioke Bennett, Gary Albert, Emmanuel Faust, Joyce S Plested, Lou Fries, Andreana Robertson, Susan Neal, Iksung Cho, Greg M Glenn, Vivek Shinde
Publikováno v:
The Lancet HIV. 9:e309-e322
There is a paucity of data on COVID-19 vaccines in people living with HIV-1, who could be at increased risk of severe illness and death from COVID-19. We evaluated the safety and immunogenicity of a Matrix-M adjuvanted recombinant spike protein nanop
Autor:
Jinal N. Bhiman, Simone I. Richardson, Bronwen E. Lambson, Prudence Kgagudi, Nonkululeko Mzindle, Haajira Kaldine, Carol Crowther, Glenda Gray, Linda-Gail Bekker, Vivek Shinde, Chijioke Bennett, Gregory M. Glenn, Shabir Madhi, Penny L. Moore, Anthonet Koen, Lee Fairlie, Leon Fouche, Qasim Bhorat, Keertan Dheda, Michele Tameris, Mduduzi Masilela, Zaheer Hoosain, Nishanta Singh, Sherika Hanley, Moherndran Archary, Cheryl Louw, Coert Grobbelaar, Umesh Lalloo, Natasha Joseph, Gertruida Kruger
The SARS-CoV-2 Omicron (B.1.1.529) Variant of Concern (VOC) and its sub-lineages (including BA.2, BA.4, BA.5, BA.2.12.1) contain spike mutations that confer high level resistance to neutralizing antibodies. The NVX-CoV2373 vaccine, a protein nanopart
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f20617718c04f1389485913a5c0f8788
https://doi.org/10.21203/rs.3.rs-2048259/v1
https://doi.org/10.21203/rs.3.rs-2048259/v1
Autor:
Ivana Beesham, Leila E. Mansoor, Dvora L. Joseph Davey, Thesla Palanee-Phillips, Jenni Smit, Khatija Ahmed, Pearl Selepe, Cheryl Louw, Mandisa Singata-Madliki, Philip Kotze, Renee Heffron, Urvi M. Parikh, Lubbe Wiesner, Helen Rees, Jared M. Baeten, Mags Beksinska
Publikováno v:
Journal of acquired immune deficiency syndromes (1999), vol 91, iss 1
BackgroundHIV endpoint-driven clinical trials provide oral pre-exposure prophylaxis (PrEP) as HIV prevention standard of care. We evaluated quantifiable plasma tenofovir among South African women who used oral PrEP during the Evidence for Contracepti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36e42eca20de1c325cea6de69fe34f15
https://escholarship.org/uc/item/0qj7s1w6
https://escholarship.org/uc/item/0qj7s1w6
Autor:
Leon Fouche, Greg Glenn, Susan Neal, Chijioke Bennett, Anthonet Koen, Tulio de Oliveira, Andreana Robertson, Asha Thombrayil, Natasha Lalloo, Lee Fairlie, Gary Albert, Iksung Cho, Mingzhu Zhu, Aylin Oommen-Jose, Zaheer Hoosain, Lou Fries, Sherika Hanley, Vicky L Baillie, Moherndran Archary, As'Ad E. Bhorat, Michele Tameris, Aliasgar Esmail, Pieter Louis Vollgraaff, Shabir A. Madhi, Filip Dubovsky, Sutika Bhikha, Friedrich G. Petrick, Annah Pitsi, Sharne Foulkes, Nazira Carrim-Ganey, Keertan Dheda, Ameena Ebrahim Goga, Gertruida Kruger, Angelique Kany Kany Luabeya, Joyce S. Plested, Dhayendre Moodley, Emmanuel Faust, Nishanta Singh, Q E Bhorat, Coert Grobbelaar, Shane Cloney-Clark, Umesh G. Lalloo, Johan Lombaard, Vivek Shinde, Mduduzi Masilela, Khatija Ahmed, Gabriella Benade, Cheryl Louw, Rosie Mngqibisa
Publikováno v:
The New England Journal of Medicine
BACKGROUND: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) pandemic. In a phase 1-2 trial involving healthy adults, the NVX-CoV2373 n
Autor:
Helen Rees, Khatija Ahmed, Katherine K. Thomas, Kate B. Heller, Kavita Nanda, Julia D Welch, Douglas Taylor, Charles S. Morrison, Cheryl Louw, James Kiarie, Gonasagrie Nair, Petrus S. Steyn, Thesla Palanee-Phillips, Peter Gichangi, Jeffrey S. A. Stringer, Zelda Nhlabatsi, Kathleen Shears, Timothy D. Mastro, Sydney Sibiya, Mandisa Singata-Madliki, Jessica Justman, G Justus Hofmeyr, Jennifer A. Smit, Mags Beksinska, Caitlin W Scoville, Raesibe Agnes Pearl Selepe, Linda-Gail Bekker, Jared M. Baeten, Deborah Donnell, Melanie Pleaner, Margaret P Kasaro, Elizabeth A. Bukusi, Maricianah Onono, Nelly Mugo
Publikováno v:
The Lancet. 394:303-313
Summary Background Observational and laboratory studies suggest that some hormonal contraceptive methods, particularly intramuscular depot medroxyprogesterone acetate (DMPA-IM), might increase women's susceptibility to HIV acquisition. We aimed to co
Autor:
G Wills, Andrew J. Nunn, J. Caoili, Mookho Malahleha, Francis Apolinary Mhimbira, Issa Sabi, Muge Cevik, Cheryl Louw, Anna Bateson, Ahmad Izuanuddin Ismail, M. C. Betteridge, Mendel Carl M, Ebrahim Variava, Daniel Everitt, Vincent Balanag, Suzanne Staples, Ronelle Moodliar, Umesh G. Lalloo, L. Lombard, Stephen H. Gillespie, Richard E. Chaisson, Robert D Hunt, Angela M. Crook, Videlis Nduba, Modulakgotla Sebe, Conor D. Tweed, Susan Swindells, Melvin Spigelman, A. Y.L. Ban, Evans Amukoye, C. H. van Niekerk, Andreas H. Diacon, Stella M. Fabiane, A. del Parigi, Rodney Dawson, R. A. P. Selepe, Francesca Conradie, Timothy D. McHugh, William Brumskine
Publikováno v:
The International Journal of Tuberculosis and Lung Disease
STAND was sponsored by TB Alliance with support from the UK Department for International Development, UK Department of Health (London, UK), Bill and Melinda Gates Foundation (Seattle, WA, USA), US Agency for International Development (Washington DC,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23754b0fb1db6916b0fbc5f98df336b9
https://hdl.handle.net/10023/21773
https://hdl.handle.net/10023/21773